Product NDC: | 0409-9630 |
Proprietary Name: | Atropine Sulfate |
Non Proprietary Name: | ATROPINE SULFATE |
Active Ingredient(s): | .05 mg/mL & nbsp; ATROPINE SULFATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-9630 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021146 |
Marketing Category: | NDA |
Start Marketing Date: | 20110629 |
Package NDC: | 0409-9630-05 |
Package Description: | 10 CARTON in 1 CONTAINER (0409-9630-05) > 1 SYRINGE, PLASTIC in 1 CARTON > 5 mL in 1 SYRINGE, PLASTIC |
NDC Code | 0409-9630-05 |
Proprietary Name | Atropine Sulfate |
Package Description | 10 CARTON in 1 CONTAINER (0409-9630-05) > 1 SYRINGE, PLASTIC in 1 CARTON > 5 mL in 1 SYRINGE, PLASTIC |
Product NDC | 0409-9630 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ATROPINE SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20110629 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | ATROPINE SULFATE |
Strength Number | .05 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |